{
  "pmid": "32822626",
  "uid": "32822626",
  "title": "Reappraisal of an ALS trial: unaccounted procedural risk.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Turnbull",
      "fore_name": "John",
      "initials": "J",
      "name": "John Turnbull",
      "affiliations": [
        "McMaster University Faculty of Health Sciences, Hamilton, ON L8N 3Z5, Canada. Electronic address: turnbull@mcmaster.ca."
      ]
    }
  ],
  "journal": {
    "title": "The Lancet. Neurology",
    "iso_abbreviation": "Lancet Neurol",
    "issn": "1474-4465",
    "issn_type": "Electronic",
    "volume": "19",
    "issue": "9",
    "pub_year": "2020",
    "pub_month": "Sep"
  },
  "start_page": "717",
  "end_page": "718",
  "pages": "717-718",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Amyotrophic Lateral Sclerosis",
    "Double-Blind Method",
    "Edaravone",
    "Humans"
  ],
  "article_ids": {
    "pubmed": "32822626",
    "doi": "10.1016/S1474-4422(20)30265-9",
    "pii": "S1474-4422(20)30265-9"
  },
  "doi": "10.1016/S1474-4422(20)30265-9",
  "dates": {
    "completed": "2020-08-28",
    "revised": "2020-08-28"
  },
  "chemicals": [
    "Edaravone"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T15:03:51.632900",
    "pmid": "32822626"
  }
}